Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vitamin D receptor polymorphism and breast cancer risk.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Nov 2002

Newcomb Polly A, Kim Han, Trentham-Dietz Amy, Farin Fredrico, Hunter David, Egan Kathleen M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Mass Index
Share to Evidence-Based Medicine
Share to Family Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Menopause

Share to Odds Ratio

Share to Receptors, Calcitriol

Share to Wisconsin

Share to Women's Health

Source

Identifiers

PMID: 12433736

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vitamin D receptor polymorphism and breast cancer risk.PMID 12433736Read ↗

What are the frequency, distribution, and functional effects of vitamin D receptor polymorphisms as related to cancer risk?Semantic proximity Read ↗

Vitamin D receptor gene (VDR) associations with cancer.Semantic proximity Read ↗

Vitamin D pathway polymorphisms in relation to mammographic breast density.Semantic proximity Read ↗

Breast Cancer Risk and Methylenetetrahydrofolate Reductase PolymorphismSemantic proximity Read ↗

Molecular epidemiology of vitamin D receptor gene variants.Semantic proximity Read ↗

Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.Semantic proximity Read ↗

Genomic vitamin D signaling in breast cancer: Insights from animal models and human cellsSemantic proximity Read ↗

XRCC1 genetic polymorphism and breast cancer risk.Semantic proximity Read ↗

BRCA1/2 carriers and endocrine risk modifiers.Semantic proximity Read ↗

Could vitamin D3 supplementation be used as a preventive strategy in genetically predisposed breast cancer? Existing evidence and future perspective.Semantic proximity Read ↗

Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease statesSemantic proximity Read ↗

ErbB4 receptor polymorphism 2368A>C and risk of breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.